Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine
- PMID: 2943952
- DOI: 10.1007/BF02934563
Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine
Abstract
Uridine and/or thymidine were administered concomitantly with 5-fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-dFUR) to mice and rats in order to establish whether the physiological nucleosides acting in vitro as antagonists can diminish fluoropyrimidine toxicity in vivo. In addition, the influence of orally co-administered uridine on antitumor activity of 5-FU and 5'-dFUR in mice has been studied. All co-administrations aggravated the general toxicity of both fluoropyrimidines. Tumor inhibition was enhanced by uridine, but the therapeutic ratio was not improved compared to monotherapy with either 5-FU or 5'-dFUR.
Similar articles
-
Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.Gan. 1980 Feb;71(1):112-23. Gan. 1980. PMID: 6445847
-
Selectivity of action of 5-FU: biochemical basis.Bull Cancer. 1979;66(1):43-7. Bull Cancer. 1979. PMID: 154352
-
The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.Jpn J Cancer Res. 1985 Oct;76(10):1034-41. Jpn J Cancer Res. 1985. PMID: 2934356
-
Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.Cancer Drug Deliv. 1987;4(3):137-44. doi: 10.1089/cdd.1987.4.137. Cancer Drug Deliv. 1987. PMID: 2967103
-
Uridine phosophorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation.Drugs Today (Barc). 2004 May;40(5):431-43. doi: 10.1358/dot.2004.40.5.850491. Drugs Today (Barc). 2004. PMID: 15319798 Review.
Cited by
-
Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.Pharm Res. 1998 Jul;15(7):1007-11. doi: 10.1023/a:1011917824836. Pharm Res. 1998. PMID: 9688052
-
Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.Cancer Chemother Pharmacol. 1988;22(1):5-10. doi: 10.1007/BF00254172. Cancer Chemother Pharmacol. 1988. PMID: 2969304
-
Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine.Cancer Chemother Pharmacol. 1989;24(1):9-14. doi: 10.1007/BF00254098. Cancer Chemother Pharmacol. 1989. PMID: 2720896
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical